InvestorsHub Logo
Followers 1
Posts 307
Boards Moderated 0
Alias Born 05/30/2007

Re: DaysOnTheBeach post# 7310

Monday, 10/01/2007 8:46:53 AM

Monday, October 01, 2007 8:46:53 AM

Post# of 146201
For the record!!

"Dr. Eugene Seymour, MD, MPH, CEO of the Company, presented results of animal studies of FluCide(TM)-I and FluCide(TM)-HP. "In our completely lethal mouse model, efficacy of FluCide-I has improved significantly, and even FluCide-HP, which is designed against high path influenzas, showed very strong efficacy against H1N1, which was the cause of 1918 Spanish Flu pandemic. The improved FluCide-I is now 16X (1,600%) better than oseltamivir (active ingredient of TamiFlu®), and FluCide-HP is 8X (800%) better than oseltamivir, based on dose-response comparisons." Further, in vitro studies have demonstrated that FluCide-HP is significantly superior to FluCide-I against H5N1, as expected."
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NNVC News